Cytotoxic 1-Deoxysphingolipids Are Metabolized by a Cytochrome P450-Dependent Pathway

Type 2 DiabetesObesity and Bariatric Surgery

Contribution of endogenous glucagon-like Peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after roux-en-Y gastric bypass (RYGB)

Metabolism.

Shah M, Laurenti MC, Man CD, Ma J, Cobelli C, Rizza RA, Vella A

doi: 10.1016/j.metabol.2018.12.005.

Type 1 DiabetesDiabetic Complications

Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes

Diabetes.

Mathew AV, Jaiswal M, Ang L, Michailidis G, Pennathur S, Pop-Busui R

doi: 10.2337/db19-0145.

Type 1 Diabetes

Comparison of a Mediterranean to a low-fat diet intervention in adults with type 1 diabetes and metabolic syndrome: A 6-month randomized trial

Nutr Metab Cardiovasc Dis.

Fortin A, Rabasa-Lhoret R, Lemieux S, Labonté ME, Gingras V

doi: 10.1016/j.numecd.

Diabetes - GeneralType 1 DiabetesGlycemic Control

Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes

Diabetologia.

Lithovius R, Toppila I, Harjutsalo V, Forsblom C, Groop PH, Mäkinen VP, FinnDiane Study Group

doi: 10.1007/s00125-017-4273-8.

Type 1 Diabetes

HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants

Diabetologia

Felton JL, Cuthbertson D, Warnock M, Lohano K, Meah F, Wentworth JM, Sosenko J, Evans-Molina C, Type 1 Diabetes TrialNet Study Group.

doi: 10.1007/s00125-021-05573-6

COMMENTED

Type 1 Diabetes

Dietary carbohydrate intake and cardio-metabolic risk factors in type 1 diabetes

Diabetes Res Clin Pract.

Ahola AJ, Forsblom C, Harjutsalo V, Groop PH, FinnDiane Study Group.

doi: 10.1016/

RECOMMENDED

Type 1 Diabetes

Impact of glycaemic control on fracture risk in 5368 people with newly diagnosed Type 1 diabetes: a time-dependent analysis

Diabet Med.

Thayakaran R, Perrins M, Gokhale KM, Kumaran S, Narendran P, Price MJ, Nirantharakumar K, Toulis KA

doi: 10.1111/dme.13945.

Diabetes - GeneralType 1 DiabetesGlycemic Control

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

Lancet Diabetes Endocrinol.

Petrie JR, Chaturvedi N, Ford I, Brouwers MCGJ, Greenlaw N, Tillin T, Hramiak I, Hughes AD, Jenkins AJ, Klein BEK, Klein R, Ooi TC, Rossing P, Stehouwer CDA, Sattar N, Colhoun HM; REMOVAL Study Group

doi: 10.1016/

Obesity and Bariatric Surgery

Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study

Metabolism.

Kouvari M, Panagiotakos DB, Yannakoulia M, Georgousopoulou E, Critselis E, Chrysohoou C, Tousoulis D, Pitsavos C; ATTICA Study Investigators

doi: 10.1016/

Related content

Contribution of endogenous glucagon-like Peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after roux-en-Y gastric bypass (RYGB)

Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes

Comparison of a Mediterranean to a low-fat diet intervention in adults with type 1 diabetes and metabolic syndrome: A 6-month randomized trial

Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes

HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants

Dietary carbohydrate intake and cardio-metabolic risk factors in type 1 diabetes

Impact of glycaemic control on fracture risk in 5368 people with newly diagnosed Type 1 diabetes: a time-dependent analysis

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study